Trevi Therapeutics, Inc.

TRVI·NasdaqGM·Healthcare
Compare
13.99+0.13 (+0.90%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13.86
Open14.35
Day range13.4814.52
52-week range9.8220.22
Off day high−3.68%
Off 52-week high−30.84%
Volume1.38M
Avg. volume (3M)1.94M
Market cap1.99B
EPS (TTM)-0.3500
Forward P/E-24.24
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.12
Shares outstanding142.48M
Short interest12.47% of float
Earnings dateNov 9, 2026
Analyst target28.18
Profit margin0.00%

Against its peers

Compare in full ›
TRVI INVA VCRE INSM BHVN AVLN
Market cap 1.99B 1.54B 265.87M 24.13B 2.30B 1.22B
P/E (TTM) — 5.0 — — — —
Forward P/E -24.2 9.6 — 168.1 -8.2 -10.6
Price/book 6.2 1.4 — 33.2 -23.4 3.1
Dividend yield — — — — — —
1-year change +30.26% +3.30% −41.91% −40.76% +78.66% −9.09%
Today +0.90% +1.58% +1.18% +5.32% −2.37% +2.46%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All TRVI news ›

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance